Cargando…

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization

BACKGROUND: To investigate the influence of benign prostatic hyperplasia (BPH) patterns detected with MRI on clinical outcomes after prostatic artery embolization (PAE). MATERIALS & METHODS: This retrospective study included 71 consecutive patients with lower urinary tract symptoms (LUTS), who u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boschheidgen, Matthias, Al-Monajjed, Rouvier, Minko, Peter, Jannusch, Kai, Ullrich, Tim, Radke, Karl Ludger, Michalski, Rene, Radtke, Jan Philipp, Albers, Peter, Antoch, Gerald, Schimmöller, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978045/ https://www.ncbi.nlm.nih.gov/pubmed/36859572 http://dx.doi.org/10.1186/s42155-023-00357-y

Ejemplares similares

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
por: Boschheidgen, M., et al.
Publicado: (2022)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
por: Quentin, M., et al.
Publicado: (2022)

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
por: Klingebiel, M, et al.
Publicado: (2022)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

Benign Prostatic Hyperplasia
Publicado: (2015)

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
por: Zhang, Jin Long, et al.
Publicado: (2018)

Prostatic Artery Embolization for the Treatment of Benign Prostate Hyperplasia: Initial Experience From Bahrain
por: Hamed Ibrahim, Wael, et al.
Publicado: (2022)

Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients
por: Xu, Chen, et al.
Publicado: (2021)

3D printed model to assist endovascular prostate artery embolization for benign prostatic hyperplasia
por: Dalla, Shiv, et al.
Publicado: (2022)

Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022)

Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis
por: Jiang, Yu-Li, et al.
Publicado: (2019)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Semi-Automatic MRI Feature Assessment in Small- and Medium-Volume Benign Prostatic Hyperplasia after Prostatic Artery Embolization
por: Schmidt, Vanessa F., et al.
Publicado: (2022)

Prostatic Artery Embolization as a Primary Treatment for Benign Prostatic Hyperplasia: Preliminary Results in Two Patients
por: Carnevale, Francisco Cesar, et al.
Publicado: (2009)

Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia
por: Hwang, Jin Ho, et al.
Publicado: (2017)

Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review
por: Sun, Fei, et al.
Publicado: (2020)

Clinical Outcomes of Prostatic Artery Embolization in Patients with Benign Prostatic Hyperplasia: A Prospective Clinical Study
por: Dogan, Kazım, et al.
Publicado: (2022)

Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection
por: Ziayee, Farid, et al.
Publicado: (2021)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
por: Ullrich, T., et al.
Publicado: (2020)

Radiological Findings of Prostatic Arterial Anatomy for Prostatic Arterial Embolization: Preliminary Study in 55 Chinese Patients with Benign Prostatic Hyperplasia
por: Zhang, Guodong, et al.
Publicado: (2015)

Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia
por: Dias, João Lopes, et al.
Publicado: (2019)

An Updated Meta-Analysis of the Efficacy and Safety of Prostatic Artery Embolization vs. Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia
por: Xu, Zhunan, et al.
Publicado: (2021)

Intra-Individual Comparison of Physiologic [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis
por: Novruzov, Emil, et al.
Publicado: (2023)

Prostatic artery embolization with polyethylene glycol microspheres: evaluation in a canine spontaneous benign prostatic hyperplasia model
por: Lucas Cava, Vanesa, et al.
Publicado: (2020)

Robotic-assisted simple prostatectomy after prostatic arterial embolization for large benign prostate hyperplasia: Initial experience
por: Kam, Sung-Chul, et al.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia
por: Garcia, Cindy, et al.
Publicado: (2015)

Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
por: Napal Lecumberri, Saturnino, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9hos4b3jgahsceug66e4eblv9d